Prudential PLC Repligen Corp Transaction History

Prudential PLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$170.78 - $208.42 $63,871 - $77,949	374 Added 13.68%	3,108 $571,000
Q4 2023 Feb 13, 2024	SELL	$114.17 - $185.35 $1,940 - $3,150	-17 Reduced 0.62%	2,734 $491,000
Q2 2023 Aug 14, 2023	BUY	$138.42 - $180.31 $126,100 - $164,262	911 Added 49.51%	2,751 $389,000
Q1 2023 May 12, 2023	SELL	$154.26 - $198.1 $133,743 - $171,752	-867 Reduced 32.03%	1,840 $309,000
Q4 2022 Feb 08, 2023	BUY	$162.42 - $220.56 $439,670 - $597,055	2,707 New	2,707 $458,000
Q2 2021 Aug 13, 2021	SELL	$165.87 - $220.95 $429,271 - $571,818	-2,588 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$180.37 - $226.26 $898,603 - $1.13 Million	-4,982 Reduced 65.81%	2,588 $503,000
Q4 2020 Feb 08, 2021	SELL	$148.08 - $206.57 $248,034 - $346,004	-1,675 Reduced 18.12%	7,570 $1.45 Million
Q3 2020 Oct 30, 2020	SELL	$122.51 - $158.27 $445,446 - $575,469	-3,636 Reduced 28.23%	9,245 $1.36 Million
Q2 2020 Jul 31, 2020	BUY	$94.33 - $140.48 $1.22 Million - $1.81 Million	12,881 New	12,881 $1.59 Million

489

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.91B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Prudential PLC, based on Form 13F filings with the SEC.

Stay updated on Prudential PLC with notifications on news.